Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup-Reference-Cited by-同舟云学术

Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup

Published:2017-03-25 Issue:45 Volume:8 Page:79188-79200
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ciabatti Elena¹²,Valetto Angelo³,Bertini Veronica³,Ferreri Maria Immacolata³,Guazzelli Alice³,Grassi Susanna¹²,Guerrini Francesca¹,Petrini Iacopo⁴,Metelli Maria Rita¹,Caligo Maria Adelaide³,Rossi Simona³,Galimberti Sara¹

Affiliation:

1. Department of Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy

2. GenOMec, University of Siena, Siena, Italy

3. Laboratory of Medical Genetics, Azienda Ospedaliero-Universitaria Pisana, S. Chiara Hospital, Pisa, Italy

4. Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HO-1 promotes resistance to an EZH2 inhibitor through the pRB-E2F pathway: correlation with the progression of myelodysplastic syndrome into acute myeloid leukemia;Journal of Translational Medicine;2019-11-11

2. Role of conventional cytogenetics in sequential karyotype analysis of myelodysplastic syndrome: a patient with der(1;7)(q10;p10);Hematology, Transfusion and Cell Therapy;2019-01

3. The genetic and molecular pathogenesis of myelodysplastic syndromes;European Journal of Haematology;2018-07-12

4. Microarray‐based comparative genomic hybridisation reveals additional recurrent aberrations in adult patients evaluated for myelodysplastic syndrome with normal karyotype;British Journal of Haematology;2018-01-09

5. Impending relapse of myelodysplastic syndrome after allogeneic transplant is difficult to diagnose and requires a multi-modal approach;BMC Clinical Pathology;2017-12